Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2010, 78(3), 562; https://doi.org/10.3797/scipharm.cespt.8.LPES01 (registering DOI)
The Potential of Continuous Processing in Secondary Manufacturing
Siemens Headquarters Pharma, Antwerp, Belgium
Siemens Industrial Automations and Druves Technology, Antwerp, Belgium
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [101 KB, uploaded 29 September 2016]
Abstract Pharmaceutical secondary manufacturing has long stood in stark contrast to the drug discovery end of the business, as well as to other sectors, when it comes to innovation such as continuous manufacturing. [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
VANGENECHTEN, R.; BACKX, I. The Potential of Continuous Processing in Secondary Manufacturing. Sci. Pharm. 2010, 78, 562.
VANGENECHTEN R, BACKX I. The Potential of Continuous Processing in Secondary Manufacturing. Scientia Pharmaceutica. 2010; 78(3):562.
VANGENECHTEN, R.; BACKX, I. 2010. "The Potential of Continuous Processing in Secondary Manufacturing." Sci. Pharm. 78, no. 3: 562.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.